Department of Health
The 2024 Post-Acute Sequelae of COVID-19 (PASC) grant opportunity will provide up to $28 million for medical research and innovation projects that:
- support the development of novel diagnostic or monitoring tools, or therapies for people living with PASC
- improve the quality of care for people who have symptoms or are living with PASC.
PASC is also known as long COVID.
This is the second grant opportunity under the $50 million MRFF PASC Research Plan. Funding is from the MRFF’s Emerging Priorities and Consumer-Driven Research initiative.
/Media Release. View in full here.
